IL6 and COVID-19: Interestingly (and in our opinion importantly), the analyses here found that COVID-19 patients with chronic CVD co-morbidities had a significantly lower IL-6 concentration than COVID-19 patients with no co-morbidities (adjusted p = 0.021).